DENVER (CBS4) - There is now a Food and Drug Administration-approved, monthly injection to treat addiction to alcohol, heroin and prescription pain pills. It's called Vivitrol. They prescribe it at ...

Please provide your email address to receive an email when new articles are posted on . Injectable naltrexone showed a more favorable safety profile than its oral counterpart and other alcohol use ...

60.5 people in Cumberland County die from drug overdoses out of every 100,000 residents. Vivitrol was introduced in 2006. Patients only have to receive Vivitrol once a month via an injection in the ...

Naltrexone has long been used to treat alcohol use disorder. Now it’s gaining attention as a tool for people who want to cut ...

The U.S. Food & Drug Adminstration has issued a warning letter to Alkermes, Inc., the makers of Vivitrol, for failing to disclose the injectable drug's most serious risks in an advertisement. Vivitrol ...

Naltrexone, an orally administered opiate receptor antagonist, has been used for the treatment of alcohol dependence in the United States since 1994. A new study examines the effectiveness of a ...

DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Results from a National Institute on Drug Abuse (NIDA)-funded study evaluating the efficacy and safety of naltrexone for extended-release injectable suspension ...

CHICAGO (WLS) -- As the raging opioid epidemic shows little sign of slowing up, a monthly shot is offering a new kind of treatment option. Vivitrol is the brand name of extended-release naltrexone, a ...

Alkermes has decided to expand the number of retail pharmacies and clinics where patients can receive access to Aristada (aripiprazole lauroxil) and Vivitrol (naltrexone extended-release injectable ...

A medication offered to heroin abusers at the Albany County jail was shown to help prevent addicts from returning to illegal drug use, according to a study published Wednesday in the New England ...

Hal Pyzyna of Lexington was 35 when he died of an opioid overdose a little more than a month after leaving an Addiction Recovery Care facility. (Photo provided) Striving to stay sober, Hal Pyzyna ...

DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Results from a National Institute on Drug Abuse (NIDA)-funded study evaluating the efficacy and safety of naltrexone for extended-release injectable suspension ...